This product is free for NEP DPG members.

This webinar was presented live on March 14, 2024.

Dr. Reddy’s current research with animal models (R01) and humans focuses on a better understanding underlying mechanism of Alzheimer's disease. Serotonin dominates neuromodulation of the brainstem and controls the forebrain neurotransmission. She hypothesizes that molecule-targeting serotonin (5HT) has a significant role in forebrain neuromodulation and increasing synaptic density in neurons resulting in neuroprotection. Dr. Reddy has 20+ years of research experience investigating serotonin mechanisms in the human central nervous system and the impact of hormones and antidepressants on the serotonin cascade.

CPE Level: 2
CPEU: 1

Performance Indicators:

• 4.1.2 Interprets and integrates evidence-based research and literature in decision-making.
• 4.2.5 Analyzes and synthesizes information and identifies new information, patterns and findings.
• 6.2.3 Analyzes and interprets data to form valid conclusions and to make recommendations.

Learning Objectives

• Describe connectivity of the 3 Ds identifying the critical component connecting systemic pathology (Diabetes) and neuropsychiatric diseases (depression) to Alzheimer’s Disease (AD) and Alzheimer’s disease-related dementias (ADRD).
• Illustrate modeling of high-fat, high glucose pathology in neurons and peripheral cells.
• Demonstrate animal behavior and conceptual learning of human behavior showing a gender dimorphic and compensatory mechanisms of the brain.

Speaker

Arubala P. Reddy PhD, RDN
Assistant Professor of Research
Nutritional Sciences Department
Texas Tech University
Lubbock, Texas